A genetic selection method for expression products that induce apoptosis in adherent mammalian cell lines

R Sandrock1, W Wheatley, E Drees

  • 1Deltagen Proteomics, Inc., 615 Arapeen Dr., Salt Lake City, UT 84108, USA.

Insights

Scientists developed a new method to find cell-killing agents by selecting for cells undergoing apoptosis, or programmed cell death. This technique uses the detachment of dying cells from cultures to identify promising cancer therapeutics.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Apoptosis, or programmed cell death, is a tightly regulated cellular process.
  • Differential sensitivity to apoptosis exists across various cell types.
  • Targeting apoptosis is a promising strategy for cancer therapy.

Purpose of the Study:

  • To develop a novel selection scheme for identifying genetic agents that induce cell killing.
  • To overcome challenges in selecting for non-proliferating apoptotic cells.
  • To enable the discovery of new therapeutic agents targeting cancer cells.

Main Methods:

  • A selection scheme based on the detachment of apoptotic mammalian cells from adherent monolayers was developed.
  • Characterization of the properties of detached (floating) apoptotic cells.
  • Evaluation of the selection process for enriching cell-killing genetic agents.

Main Results:

  • The developed selection scheme successfully enriches for genetic agents that induce cell death.
  • The detachment of apoptotic cells from monolayers serves as a reliable selection criterion.
  • The method is adaptable to various mammalian cell lines.

Conclusions:

  • A novel and effective selection method for identifying apoptosis-inducing agents has been established.
  • This technique facilitates the discovery of potential anti-cancer therapeutics.
  • The selection process is broadly applicable to mammalian cell culture systems.